Silverman Damon A, El-Hajj Michel, Strome Scott, Esclamado Ramon M
Department of Otolaryngology and Communicative Disorders, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
Arch Otolaryngol Head Neck Surg. 2003 Jul;129(7):724-8. doi: 10.1001/archotol.129.7.724.
To determine the prevalence of nodal metastases in the submuscular recess (SMR) in patients undergoing selective neck dissection (SND) and to identify potential risk factors for the presence of metastatic disease in the SMR.
Prospective cohort study.
Academic tertiary care referral center.
Consecutive patients undergoing SND for squamous cell carcinoma of the head and neck between January 5, 1998, and November 23, 2001, were prospectively analyzed. Patients with a history of neck dissection or whose pathology reports did not clearly distinguish the SMR from other nodal levels were excluded from the study.
Patients underwent SND based on the primary tumor site and well established regional lymphatic drainage patterns.Main Outcome Measure Presence of histopathologically proven nodal disease in the SMR.
Seventy-four patients underwent 90 SNDs, 16 of which were bilateral. The prevalence of metastases in the SMR was 1.6% (1/63) in clinically N0 necks and 11.1% (3/27) in clinically node-positive necks, with an overall incidence of 4.4% (4/90). There was a statistically significant association between SMR metastases and advanced pathologic N stage (P =.003), particularly with positive nodal disease in level IIa (P =.001). Extracapsular tumor spread was also shown to have a statistically significant association with metastases in the SMR (P =.01). No significant associations were observed between SMR metastases and primary tumor site (P =.06), clinical N stage (P =.09), a history of primary tumor recurrence (P =.52), or previous radiation therapy (P =.68).
The results of the present study suggest that nodal metastases in the SMR are rare in head and neck cancer patients undergoing SND.
确定接受选择性颈清扫术(SND)的患者肌下隐窝(SMR)淋巴结转移的患病率,并确定SMR中存在转移性疾病的潜在危险因素。
前瞻性队列研究。
学术性三级医疗转诊中心。
对1998年1月5日至2001年11月23日期间因头颈部鳞状细胞癌接受SND的连续患者进行前瞻性分析。有颈清扫术病史或病理报告未明确区分SMR与其他淋巴结水平的患者被排除在研究之外。
根据原发肿瘤部位和既定的区域淋巴引流模式对患者进行SND。主要观察指标为SMR中经组织病理学证实的淋巴结疾病的存在情况。
74例患者接受了90次SND,其中16次为双侧。临床N0颈部SMR转移的患病率在临床N0颈部为1.6%(1/63),在临床淋巴结阳性颈部为11.1%(3/27),总体发生率为4.4%(4/90)。SMR转移与病理N分期进展之间存在统计学显著关联(P = 0.003),特别是与IIa水平的阳性淋巴结疾病相关(P = 0.001)。肿瘤包膜外扩散也显示与SMR转移存在统计学显著关联(P = 0.01)。未观察到SMR转移与原发肿瘤部位(P = 0.06)、临床N分期(P = 0.09)、原发肿瘤复发史(P = 0.52)或既往放疗史(P = 0.68)之间存在显著关联。
本研究结果表明,在接受SND的头颈癌患者中,SMR淋巴结转移很少见。